Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03022786 · ClinicalTrials.gov registry record · NA
Improving Value of Care for Patients With Severe Stasis Dermatitis
A NA study of Stasis Dermatitis, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT03022786 is a NA study of Stasis Dermatitis that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 28 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03022786, a NA study of Stasis Dermatitis, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
Explore the unmet needs of patients admitted to the hospital for severely inflamed skin of the lower legs, often described as 'bilateral cellulitis". These patients usually have intractable lower extremity edema, stasis dermatitis and sometimes allergic contact dermatitis rather than an infectious process; readmission is common. Investigators will create patient and provider education materials to align dermatological, home health, and other resources and measure reduction in hospital re-admission rate and length of stay.
Conditions Studied
Interventions
- OTHER Order set
- OTHER Motivational Interviewing training for home health aides
- OTHER Tools & Education
Study Locations (1)
Ohio
- University Hospitals - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2017-01 |
| Est. Completion | 2018-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03022786
The ClinicalTrials.gov registry entry for NCT03022786 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Stasis Dermatitis appearing as the primary indexed condition, and to 3 interventions - of which Order set is the first listed.
NCT03022786 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT03022786 about?
NCT03022786 is a clinical study titled "Improving Value of Care for Patients With Severe Stasis Dermatitis". Explore the unmet needs of patients admitted to the hospital for severely inflamed skin of the lower legs, often described as 'bilateral cellulitis". These patients usually have intractable lower extremity edema, stasis dermatitis and sometimes allergic contact dermatitis rather than an infectious p...
What is the current status of trial NCT03022786?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2017-01. Estimated completion is 2018-12.
What conditions does trial NCT03022786 study?
This clinical trial studies the following conditions: Stasis Dermatitis.
What interventions are being tested in trial NCT03022786?
The interventions under investigation include: Order set (OTHER), Motivational Interviewing training for home health aides (OTHER), Tools & Education (OTHER).
Who is sponsoring clinical trial NCT03022786?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03022786 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.